HIP
VRTX icon

HUB Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

HUB Investment Partners’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$817K Buy
1,829
+423
+30% +$197K 0.02% 410
2025
Q4 		$637K Buy
1,406
+361
+35% +$156K 0.02% 420
2025
Q3 		$409K Buy
+1,045
New +$437K 0.01% 463

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HUB Investment Partners's VRTX Position: Q1 2026 in Review

HUB Investment Partners increased its Vertex Pharmaceuticals (VRTX) stake by 30% in Q1 2026, buying an estimated $197K and bringing the position to 1,829 shares worth $817K. The position accounts for 0.02% of the portfolio, ranked #410.

HUB Investment Partners first reported a position in VRTX in Q3 2025 and has held it in 3 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • HUB Investment Partners held 1,829 shares of Vertex Pharmaceuticals worth $817K as of Q1 2026.
  • HUB Investment Partners bought 423 Vertex Pharmaceuticals shares in Q1 2026, an estimated $197K.
  • Vertex Pharmaceuticals made up 0.02% of HUB Investment Partners's portfolio in Q1 2026, its #410 holding.
  • HUB Investment Partners first reported a position in Vertex Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on HUB Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.